1
|
Barzegar S, Asri Kojabad A, Manafi Shabestari R, Barati M, Rezvany MR, Safa M, Amani A, Pourfathollah A, Abbaspour A, Rahgoshay M, Hashemi J, Mohammadi Najafabadi M, Zaker F. Use of antioxidant nanoparticles to reduce oxidative stress in blood storage. Biotechnol Appl Biochem 2021; 69:1712-1722. [PMID: 34415072 DOI: 10.1002/bab.2240] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/15/2021] [Accepted: 08/02/2021] [Indexed: 11/09/2022]
Abstract
Oxidative damage by free radicals has a negative effect on blood quality during storage. Antioxidant nanoparticles can prevent oxidative stress. We use SOD-CAT-Alb-PEG-PLGA- nanoparticles to reduce the effects of oxidative stress in blood storage. Electrospray was employed to prepare nanoparticles. Nanoparticles entered the test bags and were kept for 35 days from the time of donation under standard conditions. On target days, experiments were performed on the samples taken. The examination included blood smear, red blood cells count, hemoglobin, hematocrit, K, Fe, glutathione peroxidase, glutathion reductase, glucose-6-phosphate dehydrogenase, prooxidant-antioxidant balance, malondialdehyde, and flow cytometric assay for phosphatidylserine. The repeated measures analysis was performed on samples every week. Morphological changes were less in the test group compared to the control. The quantitative hemolysis profile test showed significant changes in the test and control groups (p < 0.05) in consecutive weeks except for K and Fe. Oxidative stress parameters too showed a significant change during the target days of the examination (p < 0.05). Also, the phosphatidylserine expression was increased in control groups more than test in consecutive weeks (p < 0.05). It seems that the use of antioxidant nanoparticles improves the quality of stored red blood cells and can prevent posttransfusion complications and blood loss by reducing oxidative stress.
Collapse
Affiliation(s)
- Saeid Barzegar
- Department of Pathobiology and laboratory sciences, School of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran.,Department of Hematology, School of Allied Medical Sciences, Iran University of Medical Sciences, Tehran, Iran
| | - Amir Asri Kojabad
- Department of Hematology, School of Allied Medical Sciences, Iran University of Medical Sciences, Tehran, Iran
| | - Rima Manafi Shabestari
- Department of Hematology, School of Allied Medical Sciences, Iran University of Medical Sciences, Tehran, Iran
| | - Mehdi Barati
- Department of Immunology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Mohammad Reza Rezvany
- Department of Hematology, School of Allied Medical Sciences, Iran University of Medical Sciences, Tehran, Iran.,Pediatric Growth and Development Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences, Tehran, Iran.,Department of Oncology-Pathology, Immune and Gene Therapy Lab, Cancer Center Karolinska, Karolinska University Hospital Solna and Karolinska Institute, Stockholm, Sweden
| | - Majid Safa
- Department of Hematology, School of Allied Medical Sciences, Iran University of Medical Sciences, Tehran, Iran
| | - Amir Amani
- Department of Biotechnology, School of Medicine, School of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran
| | - Aliakbar Pourfathollah
- Department of Immunology, School of Medicine, Tarbiat Modares University, Iranian Blood Transfusion Research Center, Tehran, Iran
| | - Alireza Abbaspour
- Department of Pathobiology and laboratory sciences, School of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran
| | - Mahsa Rahgoshay
- Department of Hematology, School of Allied Medical Sciences, Kerman University of Medical Sciences, Kerman, Iran
| | - Javad Hashemi
- Department of Pathobiology and laboratory sciences, School of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran
| | | | - Farhad Zaker
- Department of Hematology, School of Allied Medical Sciences, Iran University of Medical Sciences, Tehran, Iran
| |
Collapse
|
2
|
Xu X, Zhu R, Ying J, Zhao M, Wu X, Cao G, Wang K. Nephrotoxicity of Herbal Medicine and Its Prevention. Front Pharmacol 2020; 11:569551. [PMID: 33178019 PMCID: PMC7593559 DOI: 10.3389/fphar.2020.569551] [Citation(s) in RCA: 18] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/05/2020] [Accepted: 08/14/2020] [Indexed: 01/31/2023] Open
Abstract
Herbal medicine (HM) has been widely used to treat diseases for thousands of years and has greatly contributed to the health of human beings. Many new drugs have been developed from HM, such as artemisinin. However, artemisinin has adverse effects, such as renal toxicity. In 1993, a study conducted in Belgium reported for the first time that the root extracts of Aristolochia obliqua S. M. Hwang led to progressive interstitial renal fibrosis. The nephrotoxicity of HM has attracted worldwide attention. More than 100 kinds of HM induce renal toxicity, including some herbs, animal HMs, and minerals. This paper aimed to summarize the HM compounds that cause nephrotoxicity, the mechanisms underlying the toxicity of these compounds, biomarkers of renal injury, and prevention strategies. These findings provide a basis for follow-up studies on the prevention and treatment of HM nephrotoxicity.
Collapse
Affiliation(s)
- Xiaofen Xu
- School of Pharmacy, Zhejiang Chinese Medical University, Hangzhou, China
| | - Ruyi Zhu
- School of Pharmacy, Zhejiang Chinese Medical University, Hangzhou, China
| | - Jialiang Ying
- School of Pharmacy, Zhejiang Chinese Medical University, Hangzhou, China
| | - Mengting Zhao
- School of Pharmacy, Guizhou University of Traditional Chinese Medicine, Guiyang, China
| | - Xin Wu
- School of Pharmacy, Zhejiang Chinese Medical University, Hangzhou, China
| | - Gang Cao
- School of Pharmacy, Zhejiang Chinese Medical University, Hangzhou, China
| | - Kuilong Wang
- School of Pharmacy, Zhejiang Chinese Medical University, Hangzhou, China
| |
Collapse
|
3
|
Potaś J, Szymańska E, Winnicka K. Challenges in developing of chitosan – Based polyelectrolyte complexes as a platform for mucosal and skin drug delivery. Eur Polym J 2020. [DOI: 10.1016/j.eurpolymj.2020.110020] [Citation(s) in RCA: 24] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
|
4
|
Sigurjonsson J, Hedman D, Bansch P, Schött U. Comparison of dextran and albumin on blood coagulation in patients undergoing major gynaecological surgery. Perioper Med (Lond) 2018; 7:21. [PMID: 30202516 PMCID: PMC6126009 DOI: 10.1186/s13741-018-0100-0] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/17/2018] [Accepted: 07/30/2018] [Indexed: 01/28/2023] Open
Abstract
Background Hydroxyethyl starches have been withdrawn from the European market. In Sweden, dextran was the main colloid until 2000, when starches overtook the market. After the recent 6S-trial, it was suggested that dextran could be reinstituted, but concerns for greater coagulopathy, bleeding and anaphylaxis still remain. An experimental study from our department indicated that isovolemic substitution of dextran-70 did not derange the von Willebrand function more than albumin 5%, considering the fact that dextran is hyperoncotic in comparison to albumin 5% and, therefore, induces a greater plasma volume expansion and thereby a greater dilutional coagulopathy. Methods Eighteen patients undergoing major gynaecological surgery were assigned to receive either 5% albumin or 6% dextran-70 with 9 patients in each group. Standard coagulation tests, including prothrombin time (PT), activated partial thromboplastin time (aPTT), fibrinogen and platelet count, viscoelastic coagulation test thromboelastometry (ROTEM) and the Multiplate platelet aggregation test were used to test for coagulation defects at different time points perioperatively. Blood loss, blood loss replacement data and haemodynamic parameters were retrieved from anaesthetic and postoperative charts. A local departmental fluid and transfusion/infusion protocol assured haemoglobin > 90 g/l and mean arterial pressure > 65 mmHg with Ringer’s acetate in addition to the colloid use. Results There were no differences in demographic data between the groups. The tissue factor-activated (EXTEM) clot-structure parameter ROTEM A10 was decreased significantly in the dextran group as compared to the albumin group after the infusion of 500 ml of either colloid solution. The PT and aPTT were significantly prolonged, and the platelet count decreased postoperatively in the dextran group, whereas albumin only deranged fibrinogen levels as compared to preoperative levels. There were no differences in Multiplate platelet aggregometry, amount of haemorrhage or transfusion of blood components between the groups. Conclusions Standard plasma-based coagulation tests, platelet count and whole blood viscoelastic clot structure are affected by 6% dextran-70 to a greater extent than by 5% albumin, but platelet aggregation is not. Future studies should use more advanced haemodynamic monitoring to assess isovolemic plasma volume expansion with dextran and whether this affects haemostasis to a lesser degree.
Collapse
Affiliation(s)
- Johann Sigurjonsson
- 1Department of Anaesthesia and Intensive Care, Institution of Clinical Science Lund, Medical Faculty, Lund University, Lund, Sweden
| | - David Hedman
- 2Department of Anaesthesia and Intensive Care, Skåne University Hospital Lund, SE-221 85 Lund, Sweden
| | - Peter Bansch
- 1Department of Anaesthesia and Intensive Care, Institution of Clinical Science Lund, Medical Faculty, Lund University, Lund, Sweden.,2Department of Anaesthesia and Intensive Care, Skåne University Hospital Lund, SE-221 85 Lund, Sweden
| | - Ulf Schött
- 1Department of Anaesthesia and Intensive Care, Institution of Clinical Science Lund, Medical Faculty, Lund University, Lund, Sweden.,2Department of Anaesthesia and Intensive Care, Skåne University Hospital Lund, SE-221 85 Lund, Sweden
| |
Collapse
|
5
|
|
6
|
Cruz MV, Luker JN, Carney BC, Brummel-Ziedins KE, Bravo MC, Orfeo T, Chen JH, Moffatt LT, Shupp JW. Reference ranges for rotational thromboelastometry in male Sprague Dawley rats. Thromb J 2017; 15:31. [PMID: 29299031 PMCID: PMC5747092 DOI: 10.1186/s12959-017-0154-0] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/25/2017] [Accepted: 12/15/2017] [Indexed: 01/24/2023] Open
Abstract
Background A functional coagulation assay was used to investigate the extrinsic pathway of coagulation on citrated whole blood samples from healthy adult male Sprague Dawley rats using the mini cup and pin system. Methods Reference values for coagulation parameters from forty-three animals were calculated using data obtained from the ROTEM® delta hemostasis analyzer with the EXTEM test. Results The following ranges, presented as the 2.5–97.5 percentiles, were established: CT [18–77], CFT [20–80], α [73–86], MCF [53–70], and ML [1–22], along with others. Conclusions These reference ranges can be used in future studies in rats to identify clinically significant coagulopathies.
Collapse
Affiliation(s)
- Mariana Vigiola Cruz
- Firefighters' Burn and Surgical Research Laboratory, MedStar Health Research Institute, Washington, DC USA.,The Burn Center, MedStar Washington Hospital Center, Washington, DC USA.,Department of Surgery, MedStar Georgetown University Hospital, Washington, DC USA
| | - Jenna N Luker
- Firefighters' Burn and Surgical Research Laboratory, MedStar Health Research Institute, Washington, DC USA
| | - Bonnie C Carney
- Firefighters' Burn and Surgical Research Laboratory, MedStar Health Research Institute, Washington, DC USA
| | | | - Maria-Cristina Bravo
- Department of Biochemistry, University of Vermont College of Medicine, Colchester, VT USA
| | - Thomas Orfeo
- Department of Biochemistry, University of Vermont College of Medicine, Colchester, VT USA
| | - Jason H Chen
- Firefighters' Burn and Surgical Research Laboratory, MedStar Health Research Institute, Washington, DC USA.,The Burn Center, MedStar Washington Hospital Center, Washington, DC USA
| | - Lauren T Moffatt
- Firefighters' Burn and Surgical Research Laboratory, MedStar Health Research Institute, Washington, DC USA.,The Burn Center, MedStar Washington Hospital Center, Washington, DC USA
| | - Jeffrey W Shupp
- Firefighters' Burn and Surgical Research Laboratory, MedStar Health Research Institute, Washington, DC USA.,The Burn Center, MedStar Washington Hospital Center, Washington, DC USA.,Department of Surgery, MedStar Washington Hospital Center, 110 Irving Street, NW; Suite 3B-55, Washington, DC 20010 USA
| |
Collapse
|